Prevalence and Clinical Impact of Electrocardiographic Abnormalities in Patients with Chronic Kidney Disease

Sejun Park, Yunjin Yum, Jung-Joon Cha, Hyung Joon Joo, Jae Hyoung Park, Soon Jun Hong, Cheol Woong Yu, Do-Sun Lim, Sejun Park, Yunjin Yum, Jung-Joon Cha, Hyung Joon Joo, Jae Hyoung Park, Soon Jun Hong, Cheol Woong Yu, Do-Sun Lim

Abstract

Chronic kidney disease (CKD) is a strong risk factor for cardiovascular disease. An electrocardiogram (ECG) is a basic test for screening cardiovascular disease. However, the impact of ECG abnormalities on cardiovascular prognosis in patients with CKD is largely unknown. A total of 2442 patients with CKD (stages 3−5) who underwent ECG between 2013 and 2015 were selected from the electronic health record database of the Korea University Anam Hospital. ECG abnormalities were defined using the Minnesota classification. The five-year major adverse cerebrocardiovascular event (MACCE), the composite of death, myocardial infarction (MI), and stroke were analyzed. The five-year incidences for MACCE were 27.7%, 20.8%, and 17.2% in patients with no, minor, and major ECG abnormality (p < 0.01). Kaplan−Meier curves also showed the highest incidence of MI, death, and MACCE in patients with major ECG abnormality. Multivariable Cox regression analysis revealed age, sex, diabetes, CKD stage, hsCRP, antipsychotic use, and major ECG abnormality as independent risk predictors for MACCE (adjusted HR of major ECG abnormality: 1.39, 95% CI: 1.09−1.76, p < 01). Among the detailed ECG diagnoses, sinus tachycardia, myocardial ischemia, atrial premature complex, and right axis deviation were proposed as important ECG diagnoses. The accuracy of cardiovascular risk stratification was improved when the ECG results were added to the conventional SCORE model (net reclassification index 0.07). ECG helps to predict future cerebrocardiovascular events in CKD patients. ECG diagnosis can be useful for cardiovascular risk evaluation in CKD patients when applied in addition to the conventional risk stratification model.

Keywords: chronic kidney disease; electrocardiogram; major adverse cerebrocardiovascular events.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier plot of cumulative incidence of (A) MACCE, (B) MI, (C) stroke, and (D) death according to ECG abnormality.

References

    1. Jeyaruban A., Hoy W., Cameron A., Healy H., Wang Z., Zhang J., Mallett A. Impact of cardiovascular events on mortality and progression of renal dysfunction in a Queensland CKD cohort. Nephrology. 2020;25:839–844. doi: 10.1111/nep.13745.
    1. Wright R.S., Reeder G.S., Herzog C.A., Albright R.C., Williams B.A., Dvorak D.L., Miller W.L., Murphy J.G., Kopecky S.L., Jaffe A.S. Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination. Ann. Intern. Med. 2002;137:563–570. doi: 10.7326/0003-4819-137-7-200210010-00007.
    1. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J. Am. Coll. Cardiol. 2002;39:1113–1119. doi: 10.1016/S0735-1097(02)01745-X.
    1. Tonelli M., Karumanchi S.A., Thadhani R. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease. Circulation. 2016;133:518–536. doi: 10.1161/CIRCULATIONAHA.115.018713.
    1. System USRD . 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. In: Bethesda M.D., editor. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System; Minneapolis, MN, USA: 2020.
    1. Jankowski J., Floege J., Fliser D., Böhm M., Marx N. Cardiovascular Disease in Chronic Kidney Disease. Circulation. 2021;143:1157–1172. doi: 10.1161/CIRCULATIONAHA.120.050686.
    1. Larsen C., Dahlin J., Blackburn H., Scharling H., Appleyard M., Sigurd B., Schnohr P. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave. The Copenhagen City Heart Study. Eur. Heart J. 2002;23:315–324. doi: 10.1053/euhj.2001.2774.
    1. Greenland P., Xie X., Liu K., Colangelo L., Liao Y., Daviglus M.L., Agulnek A.N., Stamler J. Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up. Am. J. Cardiol. 2003;91:1068–1074. doi: 10.1016/S0002-9149(03)00150-4.
    1. Sciarretta S., Pontremoli R., Rosei E.A., Ambrosioni E., Costa V., Leonetti G., Pessina A.C., Trimarco B., Francione V., Tocci G., et al. Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: Data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. J. Hypertens. 2009;27:410–417. doi: 10.1097/hjh.0b013e32831bc764.
    1. Dobre M., Brateanu A., Rashidi A., Rahman M., Salvatore S.P., Barisoni L.M.C., Herzenberg A.M., Chander P.N., Nickeleit V., Seshan S.V. Electrocardiogram Abnormalities and Cardiovascular Mortality in Elderly Patients with CKD. Clin. J. Am. Soc. Nephrol. 2012;7:949–956. doi: 10.2215/CJN.07440711.
    1. Deo R., Shou H., Soliman E.Z., Yang W., Arkin J.M., Zhang X., Townsend R.R., Go A.S., Shlipak M.G., Feldman H.I. Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD. J. Am. Soc. Nephrol. 2015;27:559–569. doi: 10.1681/ASN.2014101045.
    1. Smulyan H. The Computerized ECG: Friend and Foe. Am. J. Med. 2018;132:153–160. doi: 10.1016/j.amjmed.2018.08.025.
    1. Willems J.L., Abreu-Lima C., Arnaud P., van Bemmel J.H., Brohet C., Degani R., Denis B., Gehring J., Graham I., van Herpen G., et al. The Diagnostic Performance of Computer Programs for the Interpretation of Electrocardiograms. N. Engl. J. Med. 1991;325:1767–1773. doi: 10.1056/NEJM199112193252503.
    1. Yum Y., Shin S.Y., Yoo H., Kim Y.H., Kim E.J., Lip G.Y.H., Joo H.J. Development and Validation of 3-Year Atrial Fibrillation Prediction Models Using Electronic Health Record With or Without Standardized Electrocardiogram Diagnosis and a Performance Comparison Among Models. J. Am. Heart Assoc. 2022;11 doi: 10.1161/JAHA.121.024045.
    1. Lee D., de Keizer N., Lau F., Cornet R. Literature review of SNOMED CT use. J. Am. Med. Inform. Assoc. 2014;21:e11–e19. doi: 10.1136/amiajnl-2013-001636.
    1. Prineas R.J., Crow R.S., Zhang Z.M. The Minnesota Code Manual of Electrocardiographic Findings. 2nd ed. Springer; New York, NY, USA: 2010.
    1. Jorstad H.T., Boekholdt S.M., Wareham N.J., Khaw K.T., Peters R.J. The Dutch SCORE-based risk charts seriously underestimate the risk of cardiovascular disease. Neth. Heart J. 2017;25:173–180. doi: 10.1007/s12471-016-0927-2.
    1. Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., De Bacquer D., Ducimetière P., Jousilahti P., Keil U., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur. Heart J. 2003;24:987–1003. doi: 10.1016/S0195-668X(03)00114-3.
    1. Task Force M., Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.T., Corra U., Cosyns B., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur. J. Prev. Cardiol. 2016;23:NP1–NP96.
    1. Hlatky M.A., Greenland P., Arnett D.K., Ballantyne C.M., Criqui M.H., Elkind M.S., Go A.S., Harrell F.E., Jr., Hong Y., Howard B.V., et al. Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American Heart Association. Circulation. 2009;119:2408–2416. doi: 10.1161/CIRCULATIONAHA.109.192278.
    1. Pencina M.J., D’Agostino R.B., Sr., D’Agostino R.B., Jr., Vasan R.S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat. Med. 2008;27:157–172; discussion 207–212. doi: 10.1002/sim.2929.
    1. Graversen P., Abildstrøm S.Z., Jespersen L., Borglykke A., Prescott E. Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study. Eur. J. Prev. Cardiol. 2016;23:1546–1556. doi: 10.1177/2047487316638201.
    1. Rubin M.F., Rosas S.E., Chirinos J.A., Townsend R.R. Surrogate markers of cardiovascular disease in CKD: What’s under the hood? Am. J. Kidney Dis. 2011;57:488–497. doi: 10.1053/j.ajkd.2010.08.030.
    1. Eastwood S.V., Chaturvedi N., Sattar N., Welsh P.I., Hughes A., Tillin T. Impact of Kidney Function on Cardiovascular Risk and Mortality: A Comparison of South Asian and European Cohorts. Am. J. Nephrol. 2019;50:425–433. doi: 10.1159/000503873.
    1. Kestenbaum B., Rudser K.D., Shlipak M.G., Fried L.F., Newman A.B., Katz R., Sarnak M.J., Seliger S., Stehman-Breen C., Prineas R., et al. Kidney Function, Electrocardiographic Findings, and Cardiovascular Events among Older Adults. Clin. J. Am. Soc. Nephrol. 2007;2:501–508. doi: 10.2215/CJN.04231206.
    1. Silberberg J.S., Barre P.E., Prichard S.S., Sniderman A.D. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286–290. doi: 10.1038/ki.1989.192.
    1. Genovesi S., Rossi E., Nava M., Riva H., De Franceschi S., Fabbrini P., Viganò M.R., Pieruzzi F., Stella A., Valsecchi M.G., et al. A case series of chronic haemodialysis patients: Mortality, sudden death, and QT interval. Europace. 2013;15:1025–1033. doi: 10.1093/europace/eus412.
    1. Patzer R.E., Flueckiger P., Pastan S., Goyal A., McClellan W.W. Associations of ECG interval prolongations with mortality among ESRD patients evaluated for renal transplantation. Ann. Transplant. 2014;19:257–268. doi: 10.12659/AOT.889927.
    1. Malik M., Huikuri H., Lombardi F., Schmidt G., e-Health/Digital Rhythm Study Group of the European Heart Rhythm A The purpose of heart rate variability measurements. Clin. Auton. Res. 2017;27:139–140. doi: 10.1007/s10286-017-0416-8.
    1. Puddu P.E., Bourassa M.G., Lesperance J., Helias J., Danchin N., Goulet C. Can the mode of death be predicted in patients with angiographically documented coronary artery disease? Clin. Cardiol. 1983;6:384–395. doi: 10.1002/clc.4960060805.
    1. Cho D.-H., Choi J., Kim M.-N., Kim H.-D., Hong S.J., Yu C.W., Kim H.-L., Kim Y.H., Na J.O., Yoon H.-J., et al. Incremental value of QT interval for the prediction of obstructive coronary artery disease in patients with chest pain. Sci. Rep. 2021;11:10513. doi: 10.1038/s41598-021-90133-6.
    1. Palatini P., Reboldi G., Beilin L.J., Casiglia E., Eguchi K., Imai Y., Kario K., Ohkubo T., Pierdomenico S.D., Schwartz J.E., et al. Masked tachycardia. A predictor of adverse outcome in hypertension. J. Hypertens. 2017;35:487–492. doi: 10.1097/HJH.0000000000001194.
    1. Cheriyath P., He F., Peters I., Li X., Alagona P., Wu C., Pu M., Cascio W.E., Liao D. Relation of Atrial and/or Ventricular Premature Complexes on a Two-Minute Rhythm Strip to the Risk of Sudden Cardiac Death (the Atherosclerosis Risk in Communities [ARIC] Study) Am. J. Cardiol. 2011;107:151–155. doi: 10.1016/j.amjcard.2010.09.002.
    1. Lin C.-Y., Lin Y.-J., Chen Y.-Y., Chang S.-L., Lo L.-W., Chao T.-F., Chung F.-P., Hu Y.-F., Chong E., Cheng H.-M., et al. Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome. J. Am. Heart Assoc. 2015;4:e002192. doi: 10.1161/JAHA.115.002192.
    1. Seko Y., Kato T., Yamaji Y., Haruna Y., Nakane E., Haruna T., Inoko M. Clinical impact of left and right axis deviations with narrow QRS complex on 3-year outcomes in a hospital-based population in Japan. Sci. Rep. 2021;11:8892. doi: 10.1038/s41598-021-88259-8.
    1. Dini F.L., Demmer R., Simioniuc A., Morrone D., Donati F., Guarini G., Orsini E., Caravelli P., Marzilli M., Colombo P.C. Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. Eur. J. Heart Fail. 2012;14:287–294. doi: 10.1093/eurjhf/hfr176.
    1. Turakhia M.P., Blankestijn P.J., Carrero J.-J., Clase C.M., Deo R., Herzog C.A., Kasner S.E., Passman R.S., Pecoits-Filho R., Reinecke H., et al. Chronic kidney disease and arrhythmias: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur. Heart J. 2018;39:2314–2325. doi: 10.1093/eurheartj/ehy060.
    1. Cheema A., Singh T., Kanwar M., Chilukuri K., Maria V., Saleem F., Johnson K., Frank J., Pires L., Hassan S. Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients. Cardiol. Res. Pract. 2010;2010:989261. doi: 10.4061/2010/989261.
    1. Denes P., Larson J.C., Lloyd-Jones D., Prineas R.J., Greenland P. Major and Minor ECG Abnormalities in Asymptomatic Women and Risk of Cardiovascular Events and Mortality. JAMA. 2007;297:978–985. doi: 10.1001/jama.297.9.978.
    1. Soliman E.Z., Prineas R.J., Roediger M.P., Duprez D.A., Boccara F., Boesecke C., Stephan C., Hodder S., Stein J.H., Lundgren J.D., et al. Prevalence and prognostic significance of ECG abnormalities in HIV–infected patients: Results from the Strategies for Management of Antiretroviral Therapy study. J. Electrocardiol. 2011;44:779–785. doi: 10.1016/j.jelectrocard.2010.10.027.
    1. Jimenez-Corona A., Nelson R.G., Sievers M.L., Knowler W.C., Hanson R.L., Bennett P.H. Electrocardiographic abnormalities predict deaths from cardiovascular disease and ischemic heart disease in Pima Indians with type 2 diabetes. Am. Heart J. 2006;151:1080–1086. doi: 10.1016/j.ahj.2005.06.033.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する